TGFB1 and arteriosclerosis disorder: PAI-1, a major TGF-β1/p53 target gene and negative regulator of the plasmin-based pericellular proteolytic cascade, is elevated in arterial plaques, vessel fibrosis, arteriosclerosis, and thrombosis and correlates with increased tissue TGF-β1 levels [79].